Open access · OA
via Europe PMC
Elucidating the neuropathological and molecular heterogeneity of amyloid beta and tau in Alzheimer's disease through machine learning and transcriptomic integration.
Zhao K, Xie H, Jacobs T, Gaggi NL, Fortea J, Carlisle NB, Fonzo GA, Pohl KM, Osorio RS, Zhang Y, ADNI Study Group and the PREVENT‐AD Research Group.
Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026 · ▲ 3 citations
Abstract
<h4>Introduction</h4>Functional brain network alterations associated with Alzheimer's disease (AD) pathology, including amyloid beta (Aβ) and phosphorylated tau (p-tau), are difficult to interpret due to overlapping aging-associated and non-amyloid biological processes.<h4>Methods</h4>We analyzed resting-state functional magnetic resonance imaging (fMRI) from 289 older adults classified as Aβ-positive (A<sup>+</sup>, n = 129) or Aβ-negative (A<sup>-</sup>, n = 160) based on cerebrospinal fluid biomarkers. A contrastive deep learning framework was used to identify A<sup>+</sup>-specific network dimensions and predict individual Aβ and p-tau levels.<h4>Results</h4>A<sup>+</sup>-specific signatures were localized to the right superior temporal and anterior cingulate cortices and linked to attention and memory functions, with transcriptomic enrichment implicating synaptic dysfunction and glial activity. In contrast, signature dimensions shared between A<sup>+</sup> and A<sup>-</sup> individuals involved language-related regions and aging-associated molecular pathways.<h4>Conclusion</h4>These findings suggest that contrastive graph learning may help separate amyloid-associated functional network variation from broader background biological variability, providing insight into the heterogeneity of AD-related biomarkers and cognitive dysfunction.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1002/alz.71757
- Canonical
- link ↗
- Fetched
- 2026-10-09 MST
Cite this
APA
K, Z., H, X., T, J., NL, G., J, F., NB, C., GA, F., KM, P., RS, O., Y, Z., & Group., A.S.G.A.T.P.R. (2026). Elucidating the neuropathological and molecular heterogeneity of amyloid beta and tau in Alzheimer's disease through machine learning and transcriptomic integration. <em>Alzheimer's & dementia : the journal of the Alzheimer's Association</em>. https://doi.org/10.1002/alz.71757
Vancouver
K Z, H X, T J, NL G, J F, NB C, et al. Elucidating the neuropathological and molecular heterogeneity of amyloid beta and tau in Alzheimer's disease through machine learning and transcriptomic integration. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2026. doi:10.1002/alz.71757.
BibTeX
@article{zhao2026Elucid,
title = {Elucidating the neuropathological and molecular heterogeneity of amyloid beta and tau in Alzheimer's disease through machine learning and transcriptomic integration.},
author = {Zhao K and Xie H and Jacobs T and Gaggi NL and Fortea J and Carlisle NB and Fonzo GA and Pohl KM and Osorio RS and Zhang Y and ADNI Study Group and the PREVENT‐AD Research Group.},
journal = {Alzheimer's & dementia : the journal of the Alzheimer's Association},
year = {2026},
doi = {10.1002/alz.71757},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Yaakov Stern 2011
Open access · US-GOV
Imaging of Cognition, Learning, and Memory in Aging
PLoS ONE 2012
Open access · CC-BY
The Zinc Dyshomeostasis Hypothesis of Alzheimer's Disease
Biomarker Insights 2018
Open access · CC-BY
Reactive Oxygen Species: A Key Constituent in Cancer Survival
Massachusetts General Hospital 2015
Open access · US-GOV
Dynamic Connectivity Under Metabolic Constraints
Brain 2017
Open access · CC-BY
Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease
Istituti Clinici Scientifici Maugeri SpA 2018
Open access · US-GOV